HIST1H2BB and MAGI2 Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer.
Valle BL, Rodriguez-Torres S, Kuhn E, Díaz-Montes T, Parrilla-Castellar E, Lawson FP, Folawiyo O, Ili-Gangas C, Brebi-Mieville P, Eshleman JR, Herman J, Shih IM, Sidransky D, Guerrero-Preston R.
Valle BL, et al. Among authors: sidransky d.
Cancer Prev Res (Phila). 2020 Sep;13(9):783-794. doi: 10.1158/1940-6207.CAPR-19-0412. Epub 2020 Jun 24.
Cancer Prev Res (Phila). 2020.
PMID: 32581010
Free PMC article.